Cargando…
ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013060/ https://www.ncbi.nlm.nih.gov/pubmed/35428330 http://dx.doi.org/10.1186/s40360-022-00565-7 |
_version_ | 1784687919672328192 |
---|---|
author | Liu, Huanlong Pan, Zhenhua Ma, Xindi Cui, Junru Gao, Juan Miao, Qingfeng Zhu, Zhongning Chen, Xueyan Su, Suwen |
author_facet | Liu, Huanlong Pan, Zhenhua Ma, Xindi Cui, Junru Gao, Juan Miao, Qingfeng Zhu, Zhongning Chen, Xueyan Su, Suwen |
author_sort | Liu, Huanlong |
collection | PubMed |
description | BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in clinic, has been proved to be the most promising new drug for the treatment of PAH, with some anti-inflammatory activity. Therefore, in the present study, the effect of fasudil on lipopolysaccharide (LPS)-induced inflammatory injury in rat PMVECs was investigated. METHODS: LPS was used to make inflammatory injury model of rat PMVECs. Thereafter, the mRNA and protein expression of pro-inflammatory factors was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assay respectively. Intracellular reactive oxygen species (ROS) levels were measured by the confocal laser scanning system. The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the content of malondialdehyde (MDA) were determined by using commercial kits according to the manufacturer’s instructions. Western blot assay was used to detect the protein expression of nuclear factor kappa B (NF-κB) p65. RESULTS: Fasudil effectively prevented inflammatory injury induced by LPS, which is manifested by the decrease of pro-inflammatory cytokines interleukin-6 (IL-6) and monocyte chenotactic protein-1 (MCP-1). Meanwhile, fasudil dramatically reduced the levels of ROS and MDA, and also elevated the activities of SOD and GSH-Px. Furthermore, the nuclear translocation of NF-κB p65 induced by LPS was also suppressed by fasudil. Additionally, the ROS scavengers N-Acetylcysteine (N-Ace) was also found to inhibit the nuclear translocation of NF-κB and the mRNA expression of IL-6 and MCP-1 induced by LPS, which suggested that ROS was essential for the nuclear translocation of NF-κB. CONCLUSIONS: The present study revealed that fasudil reduced the expression of inflammatory factors, alleviated the inflammatory and oxidative damage induced by LPS in rat PMVECs via ROS-NF-κB signaling pathway. |
format | Online Article Text |
id | pubmed-9013060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90130602022-04-17 ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway Liu, Huanlong Pan, Zhenhua Ma, Xindi Cui, Junru Gao, Juan Miao, Qingfeng Zhu, Zhongning Chen, Xueyan Su, Suwen BMC Pharmacol Toxicol Research BACKGROUND: Inflammation plays a major role in the pulmonary artery hypertension (PAH) and the acute lung injury (ALI) diseases. The common feature of these complications is the dysfunction of pulmonary microvascular endothelial cells (PMVECs). Fasudil, the only Rho kinase (ROCK) inhibitor used in clinic, has been proved to be the most promising new drug for the treatment of PAH, with some anti-inflammatory activity. Therefore, in the present study, the effect of fasudil on lipopolysaccharide (LPS)-induced inflammatory injury in rat PMVECs was investigated. METHODS: LPS was used to make inflammatory injury model of rat PMVECs. Thereafter, the mRNA and protein expression of pro-inflammatory factors was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assay respectively. Intracellular reactive oxygen species (ROS) levels were measured by the confocal laser scanning system. The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the content of malondialdehyde (MDA) were determined by using commercial kits according to the manufacturer’s instructions. Western blot assay was used to detect the protein expression of nuclear factor kappa B (NF-κB) p65. RESULTS: Fasudil effectively prevented inflammatory injury induced by LPS, which is manifested by the decrease of pro-inflammatory cytokines interleukin-6 (IL-6) and monocyte chenotactic protein-1 (MCP-1). Meanwhile, fasudil dramatically reduced the levels of ROS and MDA, and also elevated the activities of SOD and GSH-Px. Furthermore, the nuclear translocation of NF-κB p65 induced by LPS was also suppressed by fasudil. Additionally, the ROS scavengers N-Acetylcysteine (N-Ace) was also found to inhibit the nuclear translocation of NF-κB and the mRNA expression of IL-6 and MCP-1 induced by LPS, which suggested that ROS was essential for the nuclear translocation of NF-κB. CONCLUSIONS: The present study revealed that fasudil reduced the expression of inflammatory factors, alleviated the inflammatory and oxidative damage induced by LPS in rat PMVECs via ROS-NF-κB signaling pathway. BioMed Central 2022-04-15 /pmc/articles/PMC9013060/ /pubmed/35428330 http://dx.doi.org/10.1186/s40360-022-00565-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Huanlong Pan, Zhenhua Ma, Xindi Cui, Junru Gao, Juan Miao, Qingfeng Zhu, Zhongning Chen, Xueyan Su, Suwen ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title | ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title_full | ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title_fullStr | ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title_full_unstemmed | ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title_short | ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway |
title_sort | rock inhibitor fasudil reduces the expression of inflammatory factors in lps-induced rat pulmonary microvascular endothelial cells via ros/nf-κb pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013060/ https://www.ncbi.nlm.nih.gov/pubmed/35428330 http://dx.doi.org/10.1186/s40360-022-00565-7 |
work_keys_str_mv | AT liuhuanlong rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT panzhenhua rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT maxindi rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT cuijunru rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT gaojuan rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT miaoqingfeng rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT zhuzhongning rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT chenxueyan rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway AT susuwen rockinhibitorfasudilreducestheexpressionofinflammatoryfactorsinlpsinducedratpulmonarymicrovascularendothelialcellsviarosnfkbpathway |